Clinical Trial Update: Using T-Cell Alloreactivity and Chimerism to Guide Immunosuppression Minimization in Intestinal Transplantation [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating whether T-cell alloreactivity and chimerism can guide immunosuppression minimization in intestinal transplantation; currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intestinal Transplantation

Snippet

Sponsor: Columbia University | Conditions: Intestinal Transplantation | Phase 1 | Status: RECRUITING